Samil Pharm (000520) — Cash Flow Reinvestment Rate
Samil Pharm (000520) has a Cash Flow Reinvestment Rate of 2.71x as of June 2025, reinvesting ₩6.62 Billion (capex ₩3.26 Billion plus investments ₩-3.36 Billion) from operating cash flow of ₩2.44 Billion. See Samil Pharm free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samil Pharm Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Samil Pharm across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Samil Pharm.
Annual Cash Flow Reinvestment Rate for Samil Pharm (2012–2024)
Year-by-year capital reinvestment analysis for Samil Pharm. See financial flexibility index of Samil Pharm to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.62x | ₩11.97 Billion | ₩2.59 Billion | ₩5.61 Billion | ▲ +22.9% |
| 2023 | 3.76x | ₩44.17 Billion | ₩11.75 Billion | ₩24.39 Billion | ▼ -73.9% |
| 2022 | 14.38x | ₩59.74 Billion | ₩4.15 Billion | ₩48.48 Billion | ▼ -52.2% |
| 2021 | 30.09x | ₩42.63 Billion | ₩1.42 Billion | ₩32.83 Billion | ▲ +711.2% |
| 2020 | 3.71x | ₩28.83 Billion | ₩7.77 Billion | ₩17.02 Billion | ▲ +117.0% |
| 2019 | 1.71x | ₩18.10 Billion | ₩10.59 Billion | ₩13.89 Billion | ▼ -84.7% |
| 2017 | 11.19x | ₩42.41 Billion | ₩3.79 Billion | ₩36.33 Billion | ▲ +762.2% |
| 2016 | 1.30x | ₩7.31 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -69.9% |
| 2015 | 4.31x | ₩12.60 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +1035.7% |
| 2012 | 0.38x | ₩1.91 Billion | ₩5.02 Billion | ₩1.91 Billion | — |